Page last updated: 2024-11-03

propranolol and B-Cell Chronic Lymphocytic Leukemia

propranolol has been researched along with B-Cell Chronic Lymphocytic Leukemia in 1 studies

Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Goin, JC1
Sterin-Borda, L1
Borda, ES1
Finiasz, M1
Fernández, J1
de Bracco, MM1

Other Studies

1 other study available for propranolol and B-Cell Chronic Lymphocytic Leukemia

ArticleYear
Active alpha 2 and beta adrenoceptors in lymphocytes from patients with chronic lymphocytic leukemia.
    International journal of cancer, 1991, Sep-09, Volume: 49, Issue:2

    Topics: Aged; Aged, 80 and over; Clonidine; Cyclic AMP; Female; Humans; Isoproterenol; Leukemia, Lymphocytic

1991